## NDAQ: Nasdaq, Inc. - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.46 indicates fundamental undervaluation. Consistent execution (4/4 quarters beat estimates). Caution: overbought RSI (76).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($94.08)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Guarantor: JPMorgan Chase & Co.**
- Source: StreetInsider | 20251222T180307 | Neutral | Relevance: 75%
- This document outlines the terms for JPMorgan Chase Financial Company LLC's structured investments consisting of $240,000 notes linked to the least performing of the Dow Jones Industrial Average, Nasdaq-100 Index, and Russell 2000 Index, due June 22, 2029. JPMorgan Chase & Co. fully and unconditionally guarantees these notes. The notes are designed for investors seeking exposure to the appreciation of these indices, with a minimum repayment of 95.00% of their principal at maturity.

**2. Lobo EV Technologies stock falls after Nasdaq compliance warning**
- Source: Investing.com India | 20251220T071016 | Somewhat-Bearish | Relevance: 74%
- Lobo EV Technologies Ltd (NASDAQ:LOBO) stock dropped 4.8% after-hours following a Nasdaq non-compliance notice. The company failed to meet the minimum bid price requirement of $1.00 per share for 30 consecutive business days. LOBO has until June 15, 2026, to regain compliance and stated it would explore all options, including a potential reverse stock split.

**3. SCYNEXIS Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement**
- Source: The Manila Times | 20251222T130951 | Neutral | Relevance: 65%
- SCYNEXIS, Inc. (NASDAQ: SCYX) has received a 180-calendar-day extension from Nasdaq to regain compliance with its minimum bid price requirement. The company now has until June 15, 2026, to maintain a closing bid price of at least $1.00 per share for ten consecutive business days. SCYNEXIS plans to advance its strategic objectives which include a Phase 1 study for an IV formulation of SCY-247 and Phase 2 data for the oral formulation of SCY-247 for invasive candidiasis infections.

**4. Walmart Stock (WMT) News and Forecast: Dec. 21, 2025 Update on Price, Analyst Targets, and 2026 Catalysts**
- Source: ts2.tech | 20251221T094356 | Neutral | Relevance: 64%
- This article provides a comprehensive update on Walmart (WMT) stock as of December 21, 2025, detailing its recent price performance, key news including a CEO transition and Nasdaq listing, and ongoing legal/regulatory risks. It also covers Walmart's strong fundamental performance with raised FY26 guidance, significant growth in advertising and e-commerce, and analyst forecasts for 2026, highlighting upcoming catalysts and risks. The overall sentiment positions Walmart as a complex "defensive growth" stock transitioning beyond a traditional retailer.

**5. Intuit Stock (INTU) Today: Stablecoin Push With Circle, OpenAI Deal, and 2026 Tax Season Catalysts Investors Are Watching**
- Source: ts2.tech | 20251222T194046 | Neutral | Relevance: 64%
- Intuit (INTU) is entering 2026 with strong catalysts, including a stablecoin partnership with Circle focusing on payments and refunds across its products. The company has also forged a major AI collaboration with OpenAI to integrate AI agents into TurboTax, QuickBooks, and Credit Karma. Additionally, new marketing initiatives for TurboTax and Credit Karma aim to capture market share for the 2026 tax season.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-22 | Morgan Stanley | $111 | $110 | +1% |
| 2025-12-12 | Barclays | $114 | $109 | +5% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-22 | Morgan Stanley | main | Overweight |
| 2025-12-12 | Barclays | main | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 6 ($2.76M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.0% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 10.4% (+6.9%)
- Investor AB: 10.2% (0.0%)
- Blackrock Inc.: 7.0% (+8.3%)
- Wellington Managemen: 7.0% (-3.5%)
- Massachusetts Financ: 4.6% (-3.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Momentum building: MRS_20 improving +2.2% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 1.46 suggests fair value with growth premium. Forward P/E 25.5x stretched relative to 11% growth. Quality metrics strong (margin 20%). Insider selling cluster ($2.8M in 90 days), potential headwind. Institutional flow bearish (5 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $55.9B |
| Beta | 1.02 |
| 52W Range | $64.84 - $97.72 |
| Short Interest | 1.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.46 |
| Forward P/E | 25.5 |
| Current P/E | 28.4 |
| YoY Growth | 11.5% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 3.7% to 5.9% (+2.2% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 88th percentile. MRS_5 at 1.4% confirms short-term momentum alignment. AM_20 at 6.5% shows strong absolute momentum above own 20MA. Outperforming sector by 3.7pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.56), confirming momentum. RSI overbought at 76, risk of mean reversion. Elevated volume (1.9x 20MA), institutional activity likely. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 5.88% (CS: 88) | Strong |
| RSI_14 | 76.2 | Overbought |
| MACD Histogram | 0.56 | Bullish |
| vs SMA20 | 1.064x | Above |
| vs SMA50 | 1.093x | Above |
| vs SMA200 | 1.130x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $97.46
- **Stop Loss:** $94.08 (3.5% risk)
- **Target:** $104.22 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 266
- **Position Value:** $25,924.36
- **Portfolio %:** 25.92%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-01-28 (Est: $0.91)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.85 | $0.88 | +3.7% |
| 2025Q2 | $0.81 | $0.85 | +4.6% |
| 2025Q1 | $0.77 | $0.79 | +2.5% |
| 2024Q4 | $0.75 | $0.76 | +1.4% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*